Skip to content

Sam's News β€” health β€” 2026-09-01

Neuroscience

7.5 Human-specific gene enables extended brain development and cognitive complexity

Scientists at Columbia University discovered that human microglia mature over 4–8 years, compared to roughly 3 weeks in mice, controlled by human-specific copies of the SRGAP2 gene. The slow maturation may contribute to the brain's cognitive complexity by allowing extended refinement of synaptic connections.

  • Human microglia mature over 4–8 years versus 3 weeks in mice
  • SRGAP2 gene nearly 10 times more abundant in human microglia than neurons
  • SRGAP2 duplicated specifically in humans, increases synaptic connections
  • Microglia comprise 5–10% of brain cells; influence synapse retention and elimination
  • Hypothesis: slow maturation contributes to brain's cognitive complexity

Sources: ScienceDaily / The Zuckerman Institute at Columbia University AI Web Searched, ScienceDaily RSS, ScienceDaily β€” Health RSS

Health

7 Mindfulness training reduces blood pressure in 8 weeks

A review of 18 randomized controlled trials found that mindfulness, gratitude, and optimism training reduced blood pressure and inflammatory markers within 8–12 weeks in adults aged 50s–60s with elevated cardiovascular risk. Programs with more frequent participant contact produced more reliable physiological benefits.

  • 8-week mindfulness training reduced systolic blood pressure
  • 12-week spirituality-based digital intervention: 7.6 mmHg systolic, 4.1 mmHg central systolic reduction
  • Lowered high-sensitivity C-reactive protein and fibrinogen
  • Reviewed 18 randomized controlled trials in adults 50s–60s with elevated CVD risk
  • More frequent contact produced most reliable physiological benefits

Sources: ScienceDaily AI Web Searched, ScienceDaily β€” Health RSS

7 Novartis wins BTK inhibitor approval for multiple sclerosis

Novartis received regulatory approval for a BTK inhibitor to treat multiple sclerosis on September 1, 2026.

  • Approval date: September 1, 2026
  • Drug class: BTK inhibitor
  • Indication: multiple sclerosis

Sources: STAT News AI Web Searched

7 New sleep apnea medication cuts breathing events by 44% in phase 3 trial

AD109, a once-nightly oral medication combining aroxybutynin and atomoxetine, reduced breathing interruptions by 44% in a phase 3 trial compared to 18% in placebo. The SynAIRgy trial enrolled 646 adults with mild to severe sleep apnea across 69 sites over six months.

  • AD109 reduced apnea-hypoxia index by ~44% versus 18% placebo
  • Phase 3 SynAIRgy trial: 646 adults, 69 sites, 6 months
  • Improves oxygen desaturation index and hypoxic burden
  • Over 40% moved to less severe OSA category; 18% achieved complete control
  • Works by strengthening throat muscles to prevent airway collapse

Sources: ScienceDaily AI Web Searched, ScienceDaily β€” Health RSS

6.5 NIH proposes cap on research grants per investigator

The NIH is considering limiting the number of grants individual researchers can receive, drawing mixed responses from the scientific community.

Sources: STAT News RSS

6.5 Dementia risk remains elevated for people over 90 despite cognitive health

Researchers found that dementia risk for people over 90 is strongly shaped by sex, race, and genetics, with women and Black participants facing higher risks.

Sources: ScienceDaily RSS, ScienceDaily β€” Health RSS

6.5 Paxlovid shows no benefit for long COVID in clinical study

A new study finds that Paxlovid did not help alleviate symptoms in patients with long COVID.

Sources: STAT News RSS

6.5 High blood sugar enables cancer cells to hide from immune system

Researchers discovered that cancer cells build a sugar-rich protective coating that thickens under high blood sugar conditions, helping them evade immune detection via the HSF1 protein.

Sources: ScienceDaily β€” Health RSS

Hardware

7 Stryker deploys Apple Vision Pro for surgical guidance system

Stryker received FDA clearance on September 1, 2026 to deploy Apple Vision Pro as a surgical guidance system, referred to as a surgical cockpit providing real-time guidance during procedures.

  • FDA clearance date: September 1, 2026
  • Uses Apple Vision Pro VR headset
  • Application: real-time surgical guidance system or 'surgical cockpit'

Sources: STAT News AI Web Searched

Policy

6.5 House weighs Trump administration plan to politicize NIH grant-making

The federal spending bill contains provisions affecting researcher funding as the Trump administration announces additional deals with pharmaceutical firms.

Sources: STAT News RSS